December 30, 2021
Research News Roundup — 2021 Q4
By Advancing the Science contributor
2021 has been another whirlwind year of COVID-19 related advances, so you might have missed all the other medical and health care delivery findings that have emerged. It would take more time than we both have to recap all the non-COVID-19 news from 2021, but if you read further, you’ll learn about some of Mayo […]
Tags: arthritis, artificial intelligence, cancer, cancer screening, cardiology, cardiovascular medicine, clinical research, clinical trials, colorectal cancer, diabetes, dialysis, EKG
May 10, 2021
Mayo Clinic Research in the news — 5/10/2021
Some Mayo Clinic research in the news this week is at the discovery level, in our genes. And at the other end of the research spectrum, better outcomes in a clinical setting — in this case, a new way to heal scars. Read the post for quick stops all along the continuum, including trauma, COVID-19, […]
Tags: Alzheimer's disease, artificial intelligence, big data, brain, Brian Kim, cancer prevention, cancer screening, Chyke Doubeni, clinical trials, colorectal cancer, data science, dementia
November 16, 2020
Mayo Clinic Research in the news — 11/16/2020
Our research and researchers showed up in a wide range of news stories over the last week, including potential benefits of coffee for patients with colorectal cancer, plus other related stories on racial disparities in screening, and recurrence of polyps. There is COVID-19 news you can use related to obesity, mental illness and valved masks. […]
Tags: allergies, Alzheimer's disease, antibiotic, anxiety, asthma, biomarkers, brain, cancer screening, Christopher Mackintosh, colon cancer, colon polyp, colorectal cancer
November 9, 2020
Mayo Clinic Research in the news — 11/9/2020
As SARS-CoV-2 spreads throughout the world, COVID-19 has become the subject of almost every conversation. Not surprisingly, the media are actively following developments in research on symptoms, testing, treatment and vaccines. In addition to some of these stories, you’ll find Mayo Clinic research and researchers highlighted across a wide range of topics. We are also […]
Tags: ALS, Alzheimer's disease, amyotrophic lateral sclerosis, animal model, bone disease, cancer screening, cardiovascular medicine, clinical research, colorectal cancer, COVID-19, David Ahlquist, dementia
October 29, 2020
Developing solutions for early detection of pancreatic cancer
By Advancing the Science contributor
By Lisa Newkirk Pancreatic cancer is one of the deadliest forms of cancer, but patients who are diagnosed at an early stage can survive five years or longer. A team at Mayo Clinic is developing patient-centered solutions for early detection of pancreatic cancer using artificial intelligence and biomarkers. This year, over 57,000 Americans will be […]
Tags: artificial intelligence, biomarkers, cancer genomics, cancer screening, collaboration, CT, DNA, Gloria Petersen, Mayo Clinic Cancer Center, pancreatic cancer, patient experience, Shounak Majumder
September 30, 2020
By Susan Murphy
Patients with a rare genetic disease called familial adenomatous polyposis, (FAP), often face debilitating challenges. Typically striking in the early teenage years, FAP is characterized by hundreds to thousands of tiny polyps forming in the colon and rectum and leading to a nearly 100% percent likelihood that they will get colon cancer without a life-altering surgery […]
Tags: cancer screening, Center for Individualized Medicine, clinical trials, colon cancer, colon polyp, colorectal cancer, gene mutation, genetic testing, hereditary diseases, Niloy "Jewel" Samadder, rare disease
April 6, 2020
Mayo Clinic Research in the News — Week in Review 4/6/2020
In the last week, as you might imagine, most of the news being covered by the media is about COVID-19. We’ve included an excerpt and link to several of these stories discussing Mayo Clinic Research. We found a couple items covering other things we are working on, so included them first, for your awareness. Study: […]
Tags: blood test, cancer, cancer screening, cardiology, clinical trials, COVID-19, FDA, Gregory Poland, Henry Ting, immune system, Mayo Clinic Laboratories, Michael Ackerman